A Randomized Pre-surgical Pharmacodynamics Study to Assess the Biological Activity of LEE011 Plus Letrozole Versus Single Agent Letrozole in Primary Breast Cancer

Trial Profile

A Randomized Pre-surgical Pharmacodynamics Study to Assess the Biological Activity of LEE011 Plus Letrozole Versus Single Agent Letrozole in Primary Breast Cancer

Discontinued
Phase of Trial: Phase II

Latest Information Update: 19 Aug 2016

At a glance

  • Drugs Ribociclib (Primary) ; Letrozole
  • Indications Breast cancer
  • Focus Pharmacodynamics
  • Acronyms MONALEESA-1
  • Sponsors Novartis Pharmaceuticals
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 18 Aug 2016 This trial has been completed in France as per European Clinical Trials Database record.
    • 31 Dec 2015 Status changed from completed to discontinued, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top